您的账号已在其他设备登录,您当前账号已强迫下线,
如非您本人操作,建议您在会员中心进行密码修改

确定
收藏 | 浏览38

Plasma cell leukemia (PCL) is a rare entity. There are two presentations of PCL, primary or secondary. The primary or de novo form of PCL presents with an acute and rapidly progressive leukemic phase. This form occurs when the patient has no pre-existing multiple myeloma (MM). The secondary form is the most advanced form of MM. The PCL is a rare disorder representing 1-2

作者:Tejinder, Singh;Cs, Premalata;Kv, Sajeevan;Ankit, Jain;Ullas, Batra;Ks, Saini;Ct, Satheesh;K Govind, Babu;D, Lokanatha

来源:Journal of laboratory physicians 2009 年 1卷 1期

知识库介绍

临床诊疗知识库该平台旨在解决临床医护人员在学习、工作中对医学信息的需求,方便快速、便捷的获取实用的医学信息,辅助临床决策参考。该库包含疾病、药品、检查、指南规范、病例文献及循证文献等多种丰富权威的临床资源。

详细介绍
热门关注
免责声明:本知识库提供的有关内容等信息仅供学习参考,不代替医生的诊断和医嘱。

收藏
| 浏览:38
作者:
Tejinder, Singh;Cs, Premalata;Kv, Sajeevan;Ankit, Jain;Ullas, Batra;Ks, Saini;Ct, Satheesh;K Govind, Babu;D, Lokanatha
来源:
Journal of laboratory physicians 2009 年 1卷 1期
标签:
Primary plasma cell leukemia multiple myeloma plasma cell dyscrasia
Plasma cell leukemia (PCL) is a rare entity. There are two presentations of PCL, primary or secondary. The primary or de novo form of PCL presents with an acute and rapidly progressive leukemic phase. This form occurs when the patient has no pre-existing multiple myeloma (MM). The secondary form is the most advanced form of MM. The PCL is a rare disorder representing 1-2